Long-Term Outcomes of Adult Patients with Homocystinuria before and after Newborn Screening
- PMID: 33239586
- PMCID: PMC7569964
- DOI: 10.3390/ijns6030060
Long-Term Outcomes of Adult Patients with Homocystinuria before and after Newborn Screening
Abstract
Background: Homocystinuria (HCU) is a rare inherited metabolic disease. In Japan, newborn screening (NBS) for HCU (cystathionine β-synthase deficiency) was initiated in 1977. We compared the outcomes between patients detected by NBS (NBS group) and clinically detected patients (non-NBS group).
Methods: We administered questionnaires about clinical symptoms and social conditions to 16 attending physicians of 19 adult HCU patients treated with methionine-free formula.
Results: Eighteen patients (nine patients each in the NBS and non-NBS groups) participated. The frequency of patients with ocular, vascular, central nervous system, and skeletal symptoms in the NBS group was lower than that in the non-NBS group. Intellectual disability was observed in one and eight patients in the NBS and non-NBS groups, respectively. Concerning their social conditions, all patients in the NBS group were employed or still attending school, while only two patients in the non-NBS group were employed. Three of the four patients who discontinued treatment presented some symptoms, even in the NBS group.
Conclusion: The social and intellectual outcomes of adult Japanese patients with HCU detected by NBS were favorable. However, even in the patients in the NBS group, some symptoms might not be preventable without continuous treatment.
Keywords: cystathionine β-synthase deficiency; homocystinuria; long-term outcome; methionine; newborn screening; social outcome; vitamin B6.
Conflict of interest statement
The authors declare that there are no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Similar articles
-
Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control.J Inherit Metab Dis. 1998 Oct;21(7):738-47. doi: 10.1023/a:1005445132327. J Inherit Metab Dis. 1998. PMID: 9819703
-
Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.Int J Neonatal Screen. 2021 Jul 23;7(3):48. doi: 10.3390/ijns7030048. Int J Neonatal Screen. 2021. PMID: 34449521 Free PMC article.
-
Early Development of Newborn Screening for HCU and Current Challenges.Int J Neonatal Screen. 2021 Oct 25;7(4):67. doi: 10.3390/ijns7040067. Int J Neonatal Screen. 2021. PMID: 34842599 Free PMC article. Review.
-
Long-Term Neurological Outcomes of Adult Patients with Phenylketonuria before and after Newborn Screening in Japan.Int J Neonatal Screen. 2021 Apr 14;7(2):21. doi: 10.3390/ijns7020021. Int J Neonatal Screen. 2021. PMID: 33919983 Free PMC article.
-
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.Semin Thromb Hemost. 2000;26(3):335-40. doi: 10.1055/s-2000-8100. Semin Thromb Hemost. 2000. PMID: 11011851 Review.
Cited by
-
Current and Novel Therapeutical Approaches of Classical Homocystinuria in Childhood With Special Focus on Enzyme Replacement Therapy, Liver-Directed Therapy and Gene Therapy.J Clin Med Res. 2023 Feb;15(2):76-83. doi: 10.14740/jocmr4843. Epub 2023 Feb 28. J Clin Med Res. 2023. PMID: 36895619 Free PMC article. Review.
-
Early Diagnosis of Classic Homocystinuria in Kuwait through Newborn Screening: A 6-Year Experience.Int J Neonatal Screen. 2021 Aug 17;7(3):56. doi: 10.3390/ijns7030056. Int J Neonatal Screen. 2021. PMID: 34449519 Free PMC article.
-
"My dream is to not have to be on a diet": a qualitative study on burdens of classical homocystinuria (HCU) from the patient perspective.Orphanet J Rare Dis. 2025 Mar 6;20(1):106. doi: 10.1186/s13023-025-03576-9. Orphanet J Rare Dis. 2025. PMID: 40045343 Free PMC article.
-
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038. Int J Neonatal Screen. 2024. PMID: 38920845 Free PMC article. Review.
-
Newborn Screening in Japan-2021.Int J Neonatal Screen. 2022 Jan 4;8(1):3. doi: 10.3390/ijns8010003. Int J Neonatal Screen. 2022. PMID: 35076455 Free PMC article.
References
-
- Morris A.A., Kozich V., Santra S., Andria G., Ben-Omran T.I., Chakrapani A.B., Crushell E., Henderson M.J., Hochuli M., Huemer M., et al. Chapman, Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J. Inherit. Metab. Dis. 2017;40:49–74. doi: 10.1007/s10545-016-9979-0. - DOI - PMC - PubMed
-
- Sacharow S.J., Picker J.D., Levy H.L. Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Stephens K., Amemiya A., editors. GeneReviews®. University of Washington; Seattle, WA, USA: 2004. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous